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Abstract
Myotonic dystrophy disorders are caused by expanded CUG repeats in non-coding regions. To
reveal mechanisms of CUG repeat pathogenesis we used C. elegans expressing CUG repeats to
identify gene inactivations that modulate CUG repeat toxicity. We identified 15 conserved genes
that function as suppressors or enhancers of CUG repeat-induced toxicity and modulate formation
of nuclear RNA foci by CUG repeats. These genes regulated CUG repeat-induced toxicity through
distinct mechanisms including RNA export and RNA clearance, suggesting that CUG repeat
toxicity is mediated by multiple pathways. A subset is shared with other degenerative disorders.
The nonsense-mediated mRNA decay (NMD) pathway plays a conserved role regulating CUG
repeat RNA transcript levels and toxicity, and NMD recognition of toxic RNAs depends on
3′UTR GC nucleotide content. Our studies suggest a broader surveillance role for NMD where
variations in this pathway influence multiple degenerative diseases.
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Introduction
Expansions in nucleotide repeat sequences cause many neuromuscular degenerative
disorders1 and can occur in noncoding as well as coding regions of genes. Expansions of
CTG repeats in the 3′ untranslated region (3′UTR) of the DMPK protein kinase gene causes
myotonic dystrophy 1 (DM1), an autosomal dominant degenerative disease2. DM1 CTG
expansions range up to >2,000 repeats; normal CTG lengths range from 5–36 repeats. RNA
toxicity is the cause of DM1 pathology, where transcripts containing expanded CUG repeats
accumulate in the nucleus as discrete RNA foci3. The length of repeat expansion correlates
with DM1 disease onset and severity4,5. Expanded CUG repeat RNA transcripts disrupt
alternative RNA splicing mediated by muscleblind-like (MBNL)6 and the CUG binding
protein 1 (CUG-BP1)7 RNA binding protein families, causing toxicity. However, disruption
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of these splicing factors, in particular of MBNL1, does not explain the many phenotypes
observed in DM disorders. The identification of new factors that function as modifiers of
DM1-associated RNA toxicity8–10, and the demonstration that in DM1 mouse models
changes are detected in mRNA transcript levels and in transcript splicing not observed in
mbnl1 knockout mice11,12, suggest the involvement of additional unknown factors and
mechanisms in expanded CUG repeat pathogenesis. Here we find that many of the
mammalian toxic features of non-coding expanded CUG repeats can be recapitulated in C.
elegans muscle. Analysis of C. elegans muscle function defects caused by expanded CUG
repeats, together with cell biological analysis of these aberrant RNAs in wild type and in
strains with a library of genes inactivated, identified gene inactivations that modify
expanded CUG repeat toxicity and CUG repeat foci accumulation, the hallmark of DM
disorders. These modifiers of expanded CUG repeat toxicity include the nonsense-mediated
mRNA decay (NMD) pathway, which targets CUG repeat-containing transcripts for
degradation. NMD regulation of CUG repeat foci accumulation is a conserved mechanism
present in both C. elegans and human cells. Recognition of these CUG repeat-containing
transcripts for degradation by NMD is dependent on repeat-sequence composition.
Results
Expanded CUG repeats cause C. elegans muscle defects
We generated a set of C. elegans reporter genes expressing GFP with 3′UTR containing
various lengths of CTG repeats in body wall muscle cells, using the myo-3 muscle-specific
promoter (Fig. 1A). Reporter constructs without any CUG repeats in the 384-nt 3′UTR from
the let-858 gene (0CUG) displayed strong GFP fluorescence at all developmental stages,
with a modest decline during adulthood. Analogous constructs with eight CUG repeats
showed similar results with mild changes in GFP fluorescence (data not shown). In contrast,
the presence of 123 CUG repeats in the 3′UTR (123CUG, a pathogenic repeat length in
mammalian myocytes) resulted in a sharp decline in GFP fluorescence as animals developed
to adults. Western blotting analyses revealed a sharp decrease in GFP protein levels in 3 day
(3d) old adult stage animals of the 123CUG strain (12% compared to protein levels at the L2
larval stage). The 3d adult stage animals of control 0CUG strain showed 50% of the GFP
levels in L2) (Fig. 1B). We used the decline in adult stage GFP fluorescence in123CUG
transgenic animals for RNAi screens to identify genes that influence toxicity of expanded
CUG repeats.
We investigated the function of C. elegans muscle expressing CUG repeats by assessing
locomotion phenotypes of these animals. We quantified motor defects by determining the
percentage of animals that reached an attractant E. coli food ring (2cm radius) on an agar
plate in 90min (Fig 1C and Supplementary Fig. 1A). The 123CUG strains exhibited severe
motility deterioration at 6d adulthood, moving about five fold slower than wild type or
control transgenic animals carrying 8CUGs or 0CUG constructs, which were similar to wild
type. We also observed earlier locomotion defects in synchronized populations of 123CUG
animals at the 2d adult stage (Supplementary Fig. 1B) and at the L4 stage (data not shown),
whereas strains’ bearing 8CUG or 0CUG repeats showed no motility defects. Thus,
Garcia et al. Page 2
Nat Struct Mol Biol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
expanded CUG repeats cause progressive muscle dysfunction as C. elegans ages, as in other
organisms including mammals13–15.
Because nuclear inclusions of expanded CUG repeat RNAs are characteristic of DM, we
investigated whether 123CUG RNA transcripts formed nuclear foci in C. elegans muscle
cells. We used single molecule RNA fluorescence in situ hybridization (SM-FISH) that has
higher sensitivity and specificity than traditional FISH16 (see Supplementary Notes). The
repeat-containing region of the expanded RNA transcript is known to interact
inappropriately with RNA-binding proteins17; therefore we chose RNA probes
complementary to the GFP sequence expected to be accessible in SM-FISH. SM-FISH
detected the accumulation of expanded mRNA transcripts in foci as ‘large’, often
amorphous, bright fluorescent structures, with 123CUG repeats mRNAs causing the
accumulation of 2 to 5 nuclear foci per cell (Fig. 1D). Many individual fluorescence spots,
likely corresponding to individual mRNAs, were also observed in the nucleus in the
123CUG strain (Fig. 1D). In contrast, animals expressing 0CUG or 8CUG repeat RNA
transcripts lacked multiple bright nuclear foci, and exhibited a predominantly cytoplasmic
distribution of RNA ‘single’ transcripts (Fig. 1D).
For a systematic analysis of all SM-FISH data to quantify foci formation and nuclear versus
cytoplasmic RNA distribution for 123CUG repeats vs controls, we developed an algorithm
that analyzed pixel intensity and cellular distribution in SM-FISH images (Supplementary
Fig. 1C–E and Supplementary Notes). We examined the SM-FISH images collected for the
nuclear versus cytoplasmic distribution of CUG repeat RNA transcripts as foci or as
‘concentrated single transcripts’ (high RNA density areas) (Supplementary Fig. 1C–E).
Consistent with the SM-FISH images (Fig. 1D), the analysis of multiple 123CUG images
showed a higher nuclear fluorescence intensity, corresponding to nuclear foci and ‘single’
RNA transcripts (Fig. 1E), clearly distinct from the control 0CUG samples. The quantitative
analysis also distinguished the 8CUG from the 0CUG samples, indicating that there are
fewer RNA transcripts in the nucleus of 8CUG animals compared to 0CUG strains.
The mammalian splicing protein MBNL1 binds to RNA transcripts containing expanded
CUG repeats6, and in myotonic dystrophy is sequestered by expanded CUG foci18. We
examined by SM-FISH and by mosaic analysis in vivo (see Supplementary Notes) whether
the C. elegans MBNL1 orthologue, MBL-119, bound the 123CUG foci detected in muscle
cells. Expression of mbl-1 in a 123CUG background caused a marked increase in foci size
relative to the 123CUG strain alone (Fig. 1F, G, Supplementary Fig. 2A–D). Mosaic
analysis showed that MBL-1 caused the retention of expanded CUG repeat RNA transcripts
in large nuclear foci disrupting transport to the cytoplasm and GFP translation
(Supplementary Fig. 2E and Supplementary Notes). These effects were not observed with
GFP mRNAs with 0CUG in a strain expressing MBL-1. Thus, as in other organisms,
MBL-1 interacts in vivo with expanded CUG transcripts in C. elegans, and MBL-1
association with expanded CUG repeat transcripts decreases mRNA export to the cytoplasm
and translation. Down-regulation of mbl-1 by RNAi did not disrupt or enhance 123CUG
transcript foci accumulation (Supplementary Fig. 2F). MBL-1 down-regulation, as we show
below, can affect the levels of expanded CUG transcript available for translation. These data
suggested that additional regulatory factors contribute to expanded CUG foci accumulation
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and toxicity. Taken together our results support the hypothesis that the RNA aggregated
transcripts identified by SM-FISH correspond to the key foci characteristic of DM.
Screen for modifiers of expanded CUG-mediated toxicity
To identify genes that mediate expanded CUG repeat RNA pathogenesis, we used RNAi to
reveal gene inactivations that can modify expanded CUG repeat RNA toxicity. A two-step
screen was performed, with an initial fluorescent-based RNAi screen, followed by a
secondary motility-based screen on hits from the primary screen (Supplementary Fig. 3A).
For the fluorescent-based screen, we assayed for gene inactivations that disrupt the late stage
down-regulation of GFP fluorescence specific to the 123CUG strain. We screened an RNAi
library of 403 clones targeting genes that encode RNA-binding proteins and factors
implicated in small RNA pathways20. This type of sub-library was expected to have a high
representation of genes involved in expanded CUG repeat toxicity. Of the 403 genes tested,
after re-screening in triplicate, 84 gene inactivations were selected that induced an increase
in late developmental stage GFP fluorescence specifically in the 123CUG strain without
affecting the control 0CUG strain (Figure 2A, Supplementary Fig. 3B, Supplementary Table
1). We tested each of the 84 gene inactivations identified for their ability to modulate the
motility defect observed in 123CUG animals (see Online Methods). The 123CUG animals
on the control RNAi showed a severe loss in motility, with a median velocity of ≈17μm/sec,
compared to the 0CUG strain on the same control RNAi at ≈100μm/sec (Fig. 2B) similar to
wild type animals. We identified 14 gene inactivations that significantly (p<0.01 using the
two-sample Kolmogorov-Smirnov test) increased or decreased the velocity of 123CUG
animals without affecting the control (0CUG) animals (Fig. 2B, Table 1).
The list of genetic modifiers of expanded CUG toxicity identified can be categorized into
the following three major classes: genes involved in transcription, signaling, and RNA
processing and degradation (Table 1). Some of the genes identified had been previously
implicated in polyglutamine (polyQ) repeat disorders: the hda-2, mrt-2 and smg-2
genes21–23, corresponding to a histone deacetylase, a RAD1 911 complex DNA damage
checkpoint protein, and a RNA helicase part of the nonsense-mediated decay pathway,
respectively. smg-2 was included in the final list as an additional gene inactivation that
affected both the 123CUG repeat transgene and the 0CUG control transgene; smg-2 gene
inactivation caused a mild decrease in motility of the 0CUG strain, but caused a much
stronger loss of motility for 123CUG repeat strain and was the strongest hit from the
fluorescent screen for suppression of the 123CUG-specific decline in GFP fluorescence. The
identification in our screen of common regulators of expanded repeat diseases supports the
view that repeat-associated disorders, where repeats occur in either coding or non-coding
regions, share several protein cofactors.
CUG toxicity modulators affect nuclear foci accumulation
We examined whether any of the 15 gene inactivations that modulated expanded CUG
repeat toxicity changed RNA foci accumulation of 123CUG transcripts. One prediction is
that gene inactivations that improve the motility of animals expressing 123CUG RNAs
would also cause a decrease in foci size or number and similarly, gene inactivations that
caused further motility impairment would lead to an increase in foci size or number (Table
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1). Of the 15 genes identified, inactivation of ocrl-1/inositol-1,4,5-triphosphate 5-
phosphatase, str-67/GPCR chemoreceptor and C06A1.6, led to an improvement of motility
in strains expressing 123CUG repeats in muscle (Table 1). Examination of GFP mRNA
localization by SM-FISH in 123CUG muscles revealed a significant reduction in the number
of nuclear foci when these three genes are inactivated (Fig. 3A, B, Supplementary Fig. 4, 5).
The suppression of 123CUG foci was particularly striking for C06A1.6 gene inactivation,
where 123CUG foci were now few and small, with SM-FISH signals close to 0CUG control
levels (Fig. 3A, Supplementary Fig. 4). However, distribution of expanded RNA ‘single’
transcripts was still observed preferentially in the nucleus versus the cytoplasm for all 3
gene inactivations, suggesting a role for ocrl-1, str-67 and C06A1.6 in foci formation rather
than in cellular distribution of RNA. No significant changes in RNA localization, and no
foci accumulation, were found in the control 0CUG strain, when these 3 genes were
inactivated (Fig. 3A, Supplementary Fig. 4, 5). Together, these data support a model in
which ocrl-1, str-67 and C06A1.6 gene activities normally enhance the toxicity of expanded
CUG repeats by contributing to 123CUG foci formation, and inactivation of these genes
results in decreased toxicity.
For the 12 gene inactivations that further reduced motility in 123CUG animals, six gene
inactivations caused an increase in foci size present in the nucleus of 123CUG body wall
muscle cells. These genes are npp-4/nuclear pore complex protein, asd-1/alternative splicing
regulator, smg-2/nonsense-mediated decay (NMD) factor, nol-9/polynucleotide 5′-hydroxyl-
kinase, dpy-22/transcriptional mediator protein and R05A10.1 (Fig. 3, Table 1,
Supplementary Fig. 4, 5). For some genes, such as npp-4, a change in RNA localization was
observed, with transcript enrichment in the nucleus relative to the cytoplasm
(Supplementary Fig. 4, 5). For all these genes, except smg-2, no significant changes in
transcript distribution were observed for the control 0CUG mRNA. smg-2 gene inactivation
in the control 0CUG led to a slight increase in transcript signal, in both the nucleus and
cytoplasm, without affecting nuclear to cytoplasm RNA distribution or leading to foci
formation. Inactivation of the other 6 genes either caused a reduction in foci sizes or did not
cause a significant change in aggregate size or number (Table 1). The reduction of foci
number associated with an increase in toxicity suggested that, in certain conditions, the
accumulation of non-aggregated CUG-expanded RNAs can be a major contributor of
cellular dysfunction. Similar to what was previously suggested24, these ‘free’ toxic RNAs
would have the potential to affect the activity of a wider range of RNA-binding proteins than
when in an ‘aggregated’ state.
To further establish that the genes identified were involved in the regulation of expanded
CUG-mediated toxicity, we overexpressed npp-4/nuclear pore complex component and
asd-1/alternative splicing regulator as mCherry fusion proteins in body wall muscle cells in
C. elegans. Down-regulation of npp-4 and asd-1 by RNAi caused an increase in nuclear
expanded CUG RNA foci sizes (Table 1). C. elegans expressing these proteins fused to the
fluorophore mCherry in either 123CUG or control 0CUG backgrounds, were analyzed by
SM-FISH for a change in accumulation of 123CUG RNA in nuclear foci. Overexpressing
either of these genes led to a decrease in foci number in a 123CUG background relative to
the 123CUG parental strain (Supplementary Fig. 6A). In contrast, overexpression of these
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proteins in the 0CUG strain had no effect on GFP mRNA transcript distribution. Expression
of mCherry alone (Fig. 1F), or a different protein, such as RNP-2, had no effect on 123CUG
foci size or number (Supplementary Fig. 6A). Thus some of the genes identified are dosage
sensitive components of the CUG repeat toxicity pathway.
Nonsense-mediated decay targets 3′ UTRs with CUG repeats
smg-2 RNAi in 123CUG animals caused an increase in nuclear RNA foci sizes, an increase
in muscle cell toxicity with loss of motility and increase in GFP fluorescence signal relative
to the control. smg-2 gene inactivation on control 0CUG strains had no effect on nuclear
foci, and the mild increase in toxicity detected was not comparable to that observed in the
123CUG strain. In addition, smg-2 acts as a common regulator of expanded repeat-
containing disorders by also suppressing protein aggregation caused by expanded CAG
repeats in the coding regions of the Huntingtin gene, associated to Huntington’s disease21.
smg-2 encodes an RNA helicase and is a conserved component of the nonsense-mediated
mRNA decay (NMD) pathway. The NMD pathway is an evolutionary conserved
surveillance mechanism that detects mRNAs containing premature stop codons, preventing
toxic expression of truncated proteins25. The identification of smg-2 as a modulator of
expanded CUG toxicity suggested that the NMD pathway may recognize and target for
degradation RNA transcripts with expanded CUG repeats, even in the 3′ UTRs of non-
truncated open reading frames. We analyzed the effects of mutations in NMD components
on GFP transcripts bearing 123CUG repeats or control 0CUG in muscle cells using
smg-1(r861), smg-2(qd101) and smg-6(r896) mutants. We observed that 123CUG animals
in the background of any of the smg mutants showed a strong increase in GFP fluorescence
signal relative to the parental strain (Fig. 4A). No such change in fluorescence was observed
for the control 0CUG animals (Fig. 4A). Quantitative RT-PCR showed that, mRNA levels
of gfp bearing 123CUG repeats were increased by several fold: ≈5.3 fold in smg-1(r861),
≈7.8 fold in smg-2(qd101) and ≈10.1 fold in smg-6(r896) backgrounds, compared to wild
type (Fig. 4B). However, no significant change was observed in the levels of gfp mRNA
without any CUG repeats in the 3′UTR in the different smg mutant backgrounds compared
to the wild type (Fig. 4B). Thus the NMD pathway targets the mRNA transcripts containing
the expanded CUG repeats for degradation.
We analyzed by SM-FISH and computational image analysis the gfp RNA transcript
accumulation in 123CUG and the control 0CUG strains in the different smg mutant
backgrounds. Disruption of NMD pathway in 123CUG animals caused an increase in foci
size and number in the nucleus (Fig. 4C, Supplementary Fig. 6B) and in most cells the
accumulation of foci-like structures in the cytoplasm as well (Fig. 4C, D, Supplementary
Fig. 6B). Conversely, in the smg mutant animals expressing the control 0CUG we observed
a uniform distribution of RNA transcripts with a large number present preferentially in the
cytoplasm (Fig. 4C, and Supplementary Fig. 6B). Thus the NMD pathway recognizes RNA
transcripts containing expanded CUG repeats and disruptions in NMD cause the
accumulation of expanded CUG toxic RNA species in the nucleus, leading to cellular
dysfunction (Supplementary Fig. 8A).
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To examine whether the skewed sequence composition of expanded CUG repeat sequences
targets them for the NMD pathway, we explored the influence of GC composition on NMD.
3′UTRs are typically A/U rich (≈65–70% AT-rich), exhibiting a nucleotide composition
distinct from coding (≈50–55% AT-rich) or intergenic regions26,27. The let-858 3′ UTR to
which the 123 CUG repeat was added is 384 nucleotides and 30% GC. The added CUG
repeat elements are rich in G and C nucleotides (≈66%) that may contribute to the
recognition by the NMD pathway. We generated expression plasmids in which the 3′UTR
(CTG)n sequence was substituted by a non-repeat sequence with either a 66% or 34% GC
nucleotide content (Supplementary Fig. 7A, B). The DNA sequences used were cloned from
non-C. elegans organisms or from entirely synthetic nucleotide sequences bearing similar
GC percentages to avoid a possible recognition of endogenous signal sequences
(Supplementary Notes). GFP reporter genes bearing GC-rich 3′ UTR elements from non-C.
elegans organisms exhibited weaker GFP fluorescence, or no fluorescence at all in the case
of synthetic sequences, compared to those bearing the corresponding AT-rich elements (Fig.
5, Supplementary Fig. 7B). Strains expressing GC-rich elements from a non-C. elegans
genome placed in the 3′UTR of the GFP reporter gene showed a significant increase in
fluorescence when either smg-1 or smg-2 were inactivated by RNAi, whereas no change in
GFP intensity was detected for AT-rich (Fig. 5, Supplementary Fig. 7A, B). Fusion genes
engineered with synthetic, random high GC percentage sequences showed a stronger
increase in fluorescence in the smg-2 background relative to two regulators of smg-2
phosphorylation smg-1 or smg-6 (Supplementary Fig. 7A, B). These data demonstrate that
the results observed for the GC-rich versus AT-rich sequences were not due to a sequence-
specific endogenous 3′ UTR identity signal present in the sequence used. These results
further establish that the increase in distance between the stop codon and the polyA signal
due to the addition of the CUG repeat sequence does not contribute to NMD recognition,
since no repression was observed for AT-rich transcripts. These data support a model in
which mRNAs, containing CUG repeats in their 3′UTR, are NMD substrates. Furthermore,
it reveals that the NMD recognition of CUG-containing mRNA is dependent on nucleotide
composition, either due to the presence of a GC-rich sequence in a region usually A/U-rich,
or due to the formation of specific secondary structures associated to the presence of these
nucleotides. While both the GC-rich 3′ UTR element and the 123CUG repeat element
reporter genes are responsive to disruption of the NMD pathway, none of the 15 gene
inactivations that strongly disable 123CUG repeat repression in muscle disrupt the
repression conferred by GC-rich element. Thus, the detection and localization to foci of
123CUG repeats by these genes is distinct from the detection and degradation of GC rich
elements by the NMD system.
To establish whether NMD recognition of expanded CUG repeats is a conserved cellular
mechanism, we analyzed the nuclear RNA foci phenotype of NMD gene inactivations in
human DM1 patient fibroblast cells expressing 2000 CUG repeats in the DMPK1 mRNA, as
well as in control fibroblasts expressing a DMPK1 mRNA with 7 to 35 such CUG repeats.
We tested for changes in foci number when the human orthologue of smg-2, UPF1, was
inactivated by RNAi. We used SM-FISH for RNA foci detection, with 5 probes
complementary to the CUG repeat region and 23 probes complementary to the last three
exons of DMPK1 which are not composed of CUG repeats. UPF1 was down-regulated using
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siRNAs in DM1 and in normal fibroblasts and these cells were analyzed by SM-FISH 24h
post siRNA-transfection. For both control fibroblasts and fibroblasts isolated from DM1
patients, UPF1 siRNAs decreased UPF1 protein levels by 35%–40% compared to scrambled
siRNAs (Supplementary Fig. 7C, D). There was lower cell recovery after UPF1 knockdown,
suggesting that knockdown of NMD components may cause a loss of cell viability, deflating
the measured level of UPF1 knockdown. But even with the modest UPF1 knockdown, SM-
FISH analysis revealed an increase in the number of nuclear foci in DM1 cells treated with
UPF1 siRNAs compared to untreated DM1 cells or DM1 cells treated with mock siRNAs
(Fig. 6A). In contrast, normal fibroblast cells bearing just a few CUG repeats in the DMPK
gene exhibited no nuclear foci in both untreated or treated with UPF1 siRNAs (Fig. 6A).
The number of foci present in the DM1 cells was quantified (see Online Methods) and UPF1
down-regulation caused a significant increase in the percentage of cells containing a higher
number of foci (Fig. 6B). Our data supports a conserved role for NMD in the identification
of transcripts bearing GC-rich sequences in their 3′UTR. Furthermore, our results support
the function of NMD as an important element in the toxicity of expanded CUG repeat
transcripts in myotonic dystrophy 1.
Discussion
The gene inactivations that modulate phenotypes of expanded CUG RNA repeats comprise
multiple pathways, beyond splicing dysregulation. We demonstrate the involvement of a
number of previously unknown genes as modulators of expanded CUG toxicity and
expanded CUG repeat foci formation. The demonstration that different gene inactivations,
all expanded CUG repeat toxicity suppressors, have opposing effects on foci accumulation
(Table 1, Supplementary Fig. 8B), supports the hypothesis that these genes act in distinct
pathways. Genes where a direct correlation exists between expanded CUG repeat toxicity
and foci accumulation (Supplementary Fig. 8B) include genes where modulation of
expanded RNA toxicity can occur by: clearance of CUG-containing RNA transcripts,
binding of expanded CUG RNA preventing foci formation or promotion of mRNA transport
from the nucleus. Inactivation of these genes causes an increase in the toxic expanded CUG
species present in the nucleus. One example is smg-2/NMD helicase inactivation. Another
class of suppressor gene inactivations do not correlate with an increase in foci formation
(Supplementary Fig. 8B); these proteins may detect cellular damage or bind to expanded
CUG repeats.
The identification in our screen of additional splicing factors, such as the asd-1 and grld-1
genes, that when inactivated caused an increase in expanded CUG toxicity was reasonable
(Table 1). Unlike MBL1 overexpression (Fig. 1F, Supplementary Fig. 2D), ASD-1
overexpression led to a decrease in expanded CUG nuclear foci accumulation
(Supplementary Fig. 6). ASD-1 is an alternative splicing factor and belongs to the Fox-1
splicing family. In vertebrates, MBNL genes are silenced by Fox-1/2 splicing factors28. Two
mechanisms for ASD-1 suppression of expanded CUG repeat toxicity emerge: 1) ASD-1
regulates functional MBNL1 levels available by modulating splicing variants; 2) ASD-1
may bind directly or indirectly to expanded CUG repeats and affect toxicity.
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Most of the gene inactivations identified make the response to expanded CUG repeats more
toxic and promote the accumulation of larger RNA foci in the nuclei, suggesting that these
genes constitute a CUG repeat detoxification pathway that blunts their toxicity.
Commonalities have been suggested in degenerative pathways between repeat-based RNA-
mediated disorders, and protein-mediated disorders1. RNA toxicity has been implicated in
polyQ expansion disorders, and MBNL1 functions as a modulator of polyQ toxicity through
its interaction with CAG-containing RNA transcripts29. A subset of the genes identified in
our screen as modifiers of expanded CUG toxicity are modulators of polyQ aggregation or
toxicity, hda-2, mrt-2 and smg-2 genes21,23. npp-4, although not previously linked to repeat
expansion disorders, is part of the nuclear pore complex together with npp-8, and npp-8 had
been identified as a modulator of polyQ aggregation30. The identification of pathways that
function as common regulators to a broad class of triplet nucleotide pathogenic expansions
supports the model of common toxic mechanisms for coding and non-coding triplet repeat
disorders.
The NMD pathway is a conserved mechanism of mRNA surveillance that regulates the
expression of 5–10% of the human, D. melanogaster and yeast transcriptomes31,32. We find
that in addition to its expected target transcripts, NMD modulates the abundance of
transcripts containing CUG repeats in their 3′UTR, reducing the accumulation and nuclear
foci formation of these toxic RNA species (Supplementary Fig. 8) in both C. elegans and
human cells (Fig. 4, 6 and Supplementary Fig. 6B). Sequence composition is key in the
recognition by NMD of RNA transcripts containing 3′UTR CUGs; a similar G/C-rich
(≈66%) sequence, when present in the 3′UTR, is also recognized by NMD, whereas an A/T-
rich sequence is not.
With the identification of NMD genes as modulators of expanded CAG repeat protein-based
disorders21, our results suggest broader surveillance roles for the NMD pathway. RNA
transcripts containing expanded CAG repeats, also GC-rich, are likely to form secondary
structures that may directly or indirectly trigger the NMD pathway33. Additionally, NMD
has been mapped to nuclear surveillance leading to nuclear RNA degradation as well as
cytoplasmic degradation. Our data showing a striking accumulation of nuclear RNA foci and
cytoplasmic RNA foci in NMD mutants suggests a role for NMD not only in the cytoplasm
but also in nuclear clearance of expanded RNA repeat transcripts.
Modulation of the NMD pathway may offer a therapeutic approach for myotonic dystrophy
patients as well as other repeat-based degenerative disorders. Pharmacological compounds
that increase NMD pathway activity may clear CUG-containing RNA toxic species, with the
potential to significantly ameliorate DM-related symptoms. A comparable approach, applied
to distinct disorders, is currently being tested in clinical trials using compounds that promote
NMD read-through34. NMD efficiency varies across tissues35 and between individuals36,37,
with significant clinical implications38. These variations in NMD efficiency may have
significant implications for trinucleotide repeat disease onset or progression.
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Online Methods
Plasmids and Constructs
Mammalian CTG repeat sequences were amplified from plasmids pR26eGFP+100 and
pR26eGFP+20039 using Extended High Fidelity from Roche in 6% DMSO and 1M betaine
(Sigma). CTG repeats were cloned into the C. elegans pPD118.20 vector bearing the myo-3
body wall muscle-specific promoter, GFP, and the let-858 3′ UTR. The mbl-1 and rnp-2
genes were amplified from C. elegans N2 genomic DNA, and asd-1 and npp-4 from cDNA,
using Phusion polymerase (Finnzymes). These genes were cloned into the C. elegans
vectors pPD49.26 and pPD30.38 (Addgene) bearing the unc-54 body wall muscle-specific
promoter. The GC-rich and AT-rich nucleotide sequences were cloned from the coding
region of the 1,4-alpha-glucan branching enzyme gene of Pseudomonas aeruginosa (glgB)
and the 3′utr region of the Arabidopsis thaliana myb domain protein 51 gene (myb51),
respectively. The synthetic GC-rich and AT rich sequences were synthesized (GenScript).
The GC-rich and AT-rich sequences were amplified and cloned into the C. elegans
pPD118.20 (Addgene) vector bearing the myo-3 body wall muscle-specific promoter.
Detailed cloning information, including primers used, is indicated in Supplementary Notes.
C. elegans Strains
Nematodes were handled using standard methods40 and experiments were performed at
20°C, unless otherwise indicated. The C. elegans N2 Bristol strain was used as wild-type
strain. Strains generated for this study are indicated in Supplementary Table 2. Transgenes
containing gfp fused to different CTG lengths were integrated by exposing animals to UV
irradiation and strains were outcrossed 5 times. Several independent strains were obtained
carrying the different GFP transgenes and the different strains generated exhibited similar
length-dependent phenotypes, as described in the Results section. The remaining transgenic
strains expressed their transgenes as extrachromosomal arrays.
RNA Fluorescence In Situ Hybridization (RNA FISH)
Oligonucleotide probes were designed and SM-FISH was performed as described in Raj et
al41. SM-FISH was performed in 3d adult animals, and in human fibroblast cells 24h post
siRNA transfection, using probes synthesized by BioSearch Technologies. Two probe sets
were used for C. elegans samples, each with thirty-four probes complementary to gfp. One
set of probes used was labeled with the dye CAL Fluor Red 590, and the other set with
Quasar 670. A distinct probe set was used for the fibroblast cell samples, comprised of
twenty-eight probes, labeled with the CAL Fluor Red 590 dye and targeting the CUG repeat
region and the 3′ region of the dmpk mammalian gene (see Supplementary Notes). DAPI
was used for nuclear staining and SM-FISH images were collected with an Olympus
FV-1000 confocal microscope with an Olympus PlanApo 60 3 Oil 1.45 NA objective at 4
zoom, and a 559 nm (mCherry/CALFluor probe), 635nm (Quasar probe) and 405nm (DAPI)
diode laser.
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SM-FISH computational image analysis
To analyze SM-FISH images, an algorithm was developed to quantify the RNA intensity
pixel by pixel in the image. Based on its intensity, each pixel was categorized into one of
three RNA populations present in the cell: ‘single’ RNAs (low RNA density), several RNA
transcripts (high RNA density), and RNA foci structures (Supplementary Fig. 1E). Pixel
intensity corresponding to fluorescence intensity correlates with the number of RNA
transcripts present41. DAPI staining was used to identify the nucleus in each cell. Because
the accumulation of foci in DM is characterized by its nuclear localization (asymmetric
cellular foci distribution), we used the cytoplasmic region in each image to normalize for
variations in staining. This approach would allow also the detection of changes in nuclear
foci accumulation. This algorithm allowed us to calculate for each nucleus the percent of
foci (pixels) and of “high density RNA” (pixels) from the total pixel population. The data
was plotted where each ‘dot’ represents a nucleus, with the Y axis representing the
percentage of foci pixels and the X axis indicating the percentage of pixels with ‘high
density’ RNA. For an example, see Supplementary Notes.
C. elegans Fluorescence Imaging
For in vivo imaging, animals were mounted on a 2% agar pad on a glass slide and
immobilized in 1mg/ml levamisole (Sigma). Fluorescence imaging was done on a Zeiss
AxioImager.Z1 Microscope.
RNAi screens
RNAi-mediated gene inactivation was by feeding42 in a 12-well plate RNAi bacterial culture
2x concentrated. Animals were synchronized by NaOCl bleaching and overnight hatching in
M9. Twenty to thirty L1 larval stage animals (≈24h after synchronization) were aliquoted
onto agar plates containing a 48h culture of RNAi bacteria expressing double-stranded
RNA, and allowed to develop to adulthood. The drug 5-fluorodexoyuridine was added at the
L4-larval stage to a final concentration of 0.1mg/ml, to inhibit progeny production. Each 12-
well plate contained the empty L4440 control vector as a negative control. Animals were
analyzed either as 3d and as 4d old adults for the GFP fluorescence screen, or at 2d old
adults for the locomotion-based toxicity screen. The RNAi clones identified as positives
from the screen were verified by sequencing of the insert. Additional information on the
RNAi screens is provided in the Supplementary Notes.
C. elegans locomotion assays
The locomotion assay on plates with a ring of OP50 food attractant was performed as
previously described43. The percentage of age-synchronized animals that reached the OP50
food in 90min was determined. The second locomotion assay, with analysis of animal
velocity, was performed at room temperature and off food. Each experiment performed
contained a control corresponding to 123CUG and 0CUG animals fed on control vector
(L4440). The locomotion behavior was recorded on a Zeiss Discovery Stereomicroscope
using Axiovision software. The center of mass was recorded for each animal on each video
frame using object-tracking software in Axiovision. Imaging began 30min after animals
were removed from food and recordings were 30sec long. For each assay, 20–45 2d old age-
Garcia et al. Page 11
Nat Struct Mol Biol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
synchronized animals were recorded. The motility data was analyzed using the two-sample
Kolmogorov-Smirnov test to compare the distributions of the values in the two data vectors
x1 and x2. The null hypothesis is that x1 and x2 are from the same continuous distribution.
This test was applied in two different ways 1) using the median velocities of all experiments
obtained from all the 123CUG or 0CUG animals fed on control vector and 2) using the
experimental internal control corresponding to the median velocity of the 123CUG or 0CUG
on control vector. RNAi clones were only considered positive if strongly significant on both
analyzes.
qRT-PCR
Total RNA was isolated from synchronized 2d old C. elegans adults using Trizol
(Invitrogen) followed by chloroform extraction and isopropanol precipitation. Samples were
DNase treated with Turbo DNA-free (Invitrogen) and cDNA was synthesized from 1μg total
RNA using Retroscript (Invitrogen). Quantitative RT-PCR assays of mRNA (SYBR Green,
Bio-Rad) levels were done according to Bio-Rad recommendations. Three independent
biological samples were used for all strains analyzed for gfp levels, and we used rpl-32
levels for normalization across samples. The 2−ΔΔct method was used for comparing relative
levels of mRNAs. Primers are listed as Supplementary information.
Protein blot assays
Proteins were extracted from synchronized animals and actin levels were used for
normalization across samples. Three independent biological samples were used for all
strains analyzed. Harvested C. elegans samples were boiled for 10min in Laemmli buffer,
spun and the supernatant collected. Proteins were resolved on 4–12% Bis-Tris SDS
polyacrilamide gels, transferred to nitrocellulose membranes and probed with GFP and actin
antibodies (Roche, Cat#11814460001; Abcam, ab3280). Protein levels were quantified on a
Typhoon phosphoimager using the ImageQuant TL software (GE Healthcare Life Sciences).
p values were calculated using Student’s t test.
Mammalian Cell Culture
Human lymphoblast cell lines were obtained from the Coriell Cell repository corresponding
to cells from unaffected individuals (GM07492) and fibroblast from DM1-affected
individuals (GM03989). Cells were maintained in high glucose EMEM (Lonza)
supplemented with 15% fetal bovine serum, 1x antibiotic-antimycotic (Gibco) and 1x non-
essential amino acids solution (Sigma), at 37°C, 5% CO2.
siRNA knockdown of UPF1 in human cells
Fibroblast cells were transfected with UPF1 ON-TARGETplus SMARTpool siRNA
(Thermo Scientific, cat. No. J-011763-05), or nontargeting siRNA as control (Thermo
Scientific, cat. No. D-001810-01) for 24h, using Lipofectamine RNAiMAX (Invitrogen)
according to the manufacturer’s protocol. The final siRNA concentration used was 100nM.
Cells were fixed after transfection for analysis by FISH as described in Raj et al41 (see
Supplementary Notes). Knockdown efficiency was monitored by Western Blotting with a
UPF1 (kindly provided by Dr. Lykke-Andersen) and GAPDH specific antibodies.
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Foci quantification in human fibroblasts
Nuclear foci in DM1-affeceted fibroblasts were quantified using the CellProfiler software
(http://www.cellprofiler.org), and specifically a script in CellProfiler, “Speckle Counting’
that allows the identification of individual cells, their nuclei, together with the number of
foci present (see Supplementary Notes). The percentage of DM1 cells containing different
numbers of nuclear foci was plotted and the p value calculated using two sample t-test
function in the Matlab package.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Expanded CUG-dependent C. elegans muscle phenotypes
(A) Diagram of CUG-containing plasmids for expression in C. elegans muscle cells, under
the myo-3 promoter. n indicates number of CUG repeats. (B) Quantification of GFP
expression levels from reporter genes with 123CUG repeats or 0 CUG repeats in the 3′UTR,
relative to actin. Graph shows mean and s.d. for 3 independent experiments, p was
determined by Student’s t test. Bottom, western blots using GFP and actin antibodies, actin
was used for sample normalization. (C) Motility assays for 6d adults. Data plotted
corresponds to average percentage of population to reach food at each time point. Error bars
represent SD from at least 3 independent experiments; in each experiment, 3–5 replicas of
ca. 100–150 animals were analyzed. (D) Confocal single molecule RNA fluorescence in situ
hybridization (SM-FISH) images of C. elegans muscle cells for GFP RNA transcripts (right,
white); nucleus are stained with DAPI (blue). Yellow arrows indicate expanded CUG
nuclear foci, and the red asterisk (●) indicates the nucleolus. (E) Computational analysis of
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SM-FISH muscle cell images of 0CUG, 8CUG and 123CUG animals. Each dot corresponds
to an analyzed SM-FISH image. The red dotted square indicates the region of clustering of
the 123CUG images (red dots). (F) confocal SM-FISH images of C. elegans muscle cells for
GFP RNA transcripts (right, white); nucleus are stained with DAPI and mCherry
fluorescence is shown on the right. The strains express GFP with 123CUG or 0CUG in a
mCHERRY or MBL-1::mCHERRY backgrounds. Yellow arrows indicate expanded CUG
nuclear foci. MBL-1::mCHERRY localizes to the nucleus. (G) Computational analysis of
SM-FISH images of 0CUG, 0CUG;mbl-1::mCherry, 123CUG and 123CUG;mbl-1::mCherry
animals.
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Figure 2.
Identification of gene inactivation that modulate expanded CUG repeat toxicity (A) Gene
inactivations that disrupt the late stage down-regulation of GFP fluorescence mediated by
123 CUG repeats in the 3′ UTR. Fluorescent microscopy images of the strains 123CUG and
the control 0CUG, on different RNAi gene inactivations: empty vector control (ctrl), npp-4,
hda-1, C06A1.6 and smg-2. Images were taken at the 3d old adult stage. Bar, 200μm. (B)
Genetic suppressors and enhancers of expanded CUG repeat toxicity. Graph of velocity
measurements of 0CUG (grey) and 123CUG (white) animals fed on different gene
inactivations. The plotted velocities (μm/sec) correspond to the median of at least two
experiments, where the red bars correspond to strains fed on control vector. Red line
indicates the median velocity, and white shading represents the 25th and 75th percentile for
the 123CUG animals fed on control vector. The dotted orange line represents the maximum
and minimum of the median velocity for 123CUG animals fed on control vector. Indicated
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by red asterisk (*) are the significant gene inactivations, where significance was determined
by Kolmogorov-Smirnov p-value. The black asterisk indicates the gene smg-2.
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Figure 3.
Suppressors and enhancers of expanded CUG toxicity affect nuclear foci. (A) Confocal SM-
FISH images of GFP RNA transcripts (white), DAPI stained nucleus (blue) and merge of C.
elegans muscle cells. Shown are 123CUG and the 0CUG control in different RNAi gene
inactivations: empty vector control (ctrl), C06A1.6 and npp-4. Yellow arrows indicate
expanded CUG nuclear foci. (B) Computational analysis of SM-FISH images of 123CUG
animals with different gene inactivations and control (ctrl). Results are plotted as bar graphs
were gene inactivations corresponding to bars on the right of the control exhibit an increase
in detected foci area (in red), and conversely bars on the left of the control exhibit a decrease
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in foci area (in green), relative to the control. The cfim-2 and F48E8.6 gene inactivations are
similar to ctrl. (C) C. elegans muscle cells confocal SM-FISH images of GFP RNA
transcripts (white), DAPI stained nucleus (blue), merge of GFP RNA and nucleus images,
and mCherry translational fusion protein. Strains imaged are 123CUG and 0CUG animals,
in a mCHERRY (control) or NPP-4::mCHERRY backgrounds. Yellow arrows indicate
expanded CUG nuclear foci.
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Figure 4.
The NMD pathway modulates expanded CUG transcripts degradation and nuclear foci
accumulation. (A) Fluorescent microscopy images of 2d old adult animals expressing either
123CUG repeats or 0CUG in the backgrounds: wild type (wt), smg-2(qd101), smg-1(r861)
and smg-6(r896). Scale bars correspond to 200μm. (B) qRT-PCR assay for gfp levels in
animals expressing either 123CUG repeats or the control GFP in different backgrounds:
wild type (wt), smg-2(qd101), smg-1(r861) and smg-6(r896). Wild type=1.0. Error bars
represent SEM for three biological replicates. (C) Confocal SM-FISH images of GFP RNA
transcripts (white), DAPI stained nucleus (blue) and merge of C. elegans muscle cells. The
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strains imaged are 123CUG and 0CUG animals, in wild type (wt) and smg-2(qd101).
Yellow arrows indicate expanded CUG nuclear foci. (D) Computational analysis of SM-
FISH images of 0CUG (green dots), 0CUG in smg mutant backgrounds (blue dots),
123CUG (red dots) and 123CUG in smg mutant backgrounds (black dots).
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Figure 5.
3′UTR CUG repeat sequence composition triggers NMD recognition for degradation.
Fluorescent microscopy images of the strains 123CUG, GC-rich and AT-rich, in different
RNAi gene inactivations: empty vector control (ctrl), smg-1, smg-2, and smg-6. Images of
3d old adult animals. Bar, 200μm.
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Figure 6.
NMD downregulation causes an increase in CUG repeat mRNA foci number in myotonic
dystrophy 1 patient fibroblast cells. (A) SM-FISH of DM1-affected or normal human
fibroblast cells in which UPF1 was downregulated relative to control non-transfected or
transfected with scrambled siRNAs (mock) cells. The DM1 human fibroblast cell line used
expressed the gene dmpk bearing 2000CUG in its 3′UTR. (B) Histogram represents the
distribution of the number of foci in DM1 cells that were downregulated for UPF1, mock
and non-transfected controls. UPF1 downregulation led to a significant increase in the
number of nuclear foci present relative to mock (p<0.0001) and non-transfected cells
(p<0.00003), using t-student test. N indicates the total number of cells analyzed. Two
independent experiments were performed. Bar, 5μm.
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